Skip to content

Application of Multimodal Large Language Models for Assisting in the Screening of Heart Failure

Application of a multimodal large language model in the screening of heart failure with preserved ejection fraction

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500104332
Enrollment
Unknown
Registered
2025-06-16
Start date
2025-06-26
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure

Interventions

Gold Standard:Clinical diagnosis of heart failure combined with echocardiographic assessment (including left ventricular diastolic function, left atrial enlargement, and BNP/NT-proBNP levels), determi
Index test:A multimodal large language model (integrating text and image inputs) for assisting in the screening of HFpEF.

Sponsors

Handan First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-80 years, male or female; 2. Inpatients in the Department of Cardiology suspected of heart failure (cardiac ultrasound showed abnormal cardiac function, meeting at least one of the following: 1). left ventricular hypertrophy and/or left atrial enlargement; 2). abnormal cardiac diastolic function); 3. At least one symptom of heart failure currently or in the past, including dyspnea (including exertional dyspnea, nocturnal paroxysmal dyspnea, orthopnea), fatigue, poor appetite and edema of both lower limbs; 4. Voluntary participation and signing of the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Acute heart failure or acute deterioration of chronic heart failure; 2. Severe coronary artery stenosis (>= 75% stenosis) without revascularization therapy; 3. Patients who are unable to undergo exercise stress echocardiography or have contraindications to the examination; 4. Participating in other clinical trials; 5. Patients with severe organic lesions or chronic diseases such as liver, kidney, and blood system; 6. Unable to follow the trial procedures; 7. Refusing to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
The diagnostic specificity of HFpEF in the screening mode between the experimental group and the control group;Diagnostic sensitivity of screening patterns in the experimental and control groups for HFpEF;The diagnostic consistency of HFpEF between the screening modes of the experimental group and the control group.;

Secondary

MeasureTime frame
Diagnosis time, comparing the time required to diagnose heart failure between the two groups;Patient Satisfaction: Assess the patient's satisfaction with the diagnostic process.;Long-term effects of diagnostic accuracy;Economic cost analysis;Misdiagnosis rate;Physician workload assessment;Efficiency of the diagnostic process;

Countries

China

Contacts

Public ContactMiao Mengdan

Handan First Hospital

m18032936267@163.com+86 176 0022 0171

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026